Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-022591
Filing Date
2023-06-20
Accepted
2023-06-20 06:36:29
Documents
15
Period of Report
2023-06-19

Document Format Files

Seq Description Document Type Size
1 6-K a230620_6kxmorxvotingright.htm 6-K 12662
2 EX-99.1 exhibit991.htm EX-99.1 6791
3 EX-99.2 exhibit992.htm EX-99.2 6952
4 GRAPHIC exhibit991001.jpg GRAPHIC 131511
5 GRAPHIC exhibit991002.jpg GRAPHIC 122474
6 GRAPHIC exhibit991003.jpg GRAPHIC 120759
7 GRAPHIC exhibit991004.jpg GRAPHIC 91895
8 GRAPHIC exhibit991005.jpg GRAPHIC 103128
9 GRAPHIC exhibit991006.jpg GRAPHIC 28231
10 GRAPHIC exhibit992001.jpg GRAPHIC 131423
11 GRAPHIC exhibit992002.jpg GRAPHIC 122989
12 GRAPHIC exhibit992003.jpg GRAPHIC 120810
13 GRAPHIC exhibit992004.jpg GRAPHIC 91025
14 GRAPHIC exhibit992005.jpg GRAPHIC 102411
15 GRAPHIC exhibit992006.jpg GRAPHIC 47569
  Complete submission text file 0001628280-23-022591.txt   1700650
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 231023303
SIC: 2834 Pharmaceutical Preparations